LITTLE ROCK, Ark. -- The Arkansas Department of Health along with federal health organizations and other states are investigating reports of infections among 20 patients in Illinois (5), North Carolina (2), and Florida (13) who received injections of a steroid, methylprednisolone acetate (MPA), after Dec. 6, 2012, produced by Main Street Family Pharmacy, LLC, (MSFP) in Newbern, Tenn. Complications identified thus far appear to be limited to skin abscesses at the site of injection and joint infections. There are no reports of meningitis, stroke or death.
Ten clinics in Arkansas have received MPA from the MSFP. All ten have been contacted and are assembling information to assist in the investigation. Individuals who are experiencing any unexplained health problems following an injection of methylprednisolone acetate from one of these clinics are encouraged to contact the clinic or their regular health care provider.
The clinics include: Antoon Medical Clinic in Stamps; Lofton Family Clinic in DeQueen; Ouachita Family Practice in Mena; Reinhart Family Healthcare in Monticello; Monticello Medical Clinic in Monticello; Southern Medical Group in Magnolia; Chambliss & Davis Clinic in Magnolia; Coast to Coast Medical in West Memphis; Family Medicine in White Hall; Integrated Health in Fayetteville.
The investigation began after the FDA was notified of two individuals who developed complications after being administered this product at a clinic in Greenville, NC. On May 28th, 2013, the MSFP issued a voluntary recall of all sterile products. Arkansas is among at least 15 states including Alabama, California, Florida, Kentucky, Illinois, Louisiana, Mississippi, New Mexico, North Carolina, South Carolina, Tennessee, Montana, Oklahoma, and Texas where the products were distributed.
The organizations involved in the investigation include the Food and Drug Administration, the Centers for Disease Control and Prevention, the Illinois Department of Health, the North Carolina Department of Health and Human Services and the Tennessee Department of Health. Because the investigation is in an early stage, staff members with all agencies are working now to gather and process information and to communicate with affected facilities and patients.